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Sunnnary: The complete amino acid sequence of carbonic anhydrase I (CA I) 
isolated from the red cells of the rhesus macaque (Macaca mulatta) is present- -- 
ed. This sequence was obtained by aligning peptides derived from various 
fragmentation procedures with the fully characterized sequence of human CA I. 
When the peptides of rhesus CA I were ordered in this manner, 13 of the 260 
residues were found to differ from the human CA I sequence. The known mark- 
edly higher specific esterase activity of rhesus CA I compared to human CA I 
could not be correlated with any changes in residues postulated to be within 
10 W of the single zinc ion at the active site. 
INTRODUCTION 
Mammalian carbonic anhydrases (EC 4.2.1-l.) are known to occur as three 
isosymss, designated CA I, CA II and CA III, which are the products of sepa- 
rate genetic loci (l-6). CA I is found in red cells and in regions of a 
limited number of tissues (e.g., colonic mucosa, rumen epithelium, pituitary 
gland), whereas CA II is found in red cells and a much wider variety of tis- 
sues (cf. 1). CA III appears to be found mainly in red skeletal muscle (7-9). 
These three isozymes which differ, sometimes markedly, in some of their 
physico-chemical and catalytic properties are all monomeric metalloenzymes 
(M.W. -29,000) containing an essential zinc ion in the active site (cf. 3, 10, 
11). 
The complete amino acid sequence of eight carbonic anhydrase isosymes 
have been reported. These are: human CA I (12-14), horse CA I (15), ox CA I 
(3), human CA II (16,17), sheep CA II (18), ox CA II (19), rabbit CA II (20) 
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and ox CA III (3). Comparisons of the complete primary structure of all of 
these isozymes (including rhesus CA I) show that about 37% of the residues at 
homologous positions are invariant, indicating that these isozymes have 
evolved from a common ancestral gene. Here, we report the complete primary 
structure of CA I from the rhesus macaque monkey, Macaca mulatta. This -- 
represents part of our continuing studies to obtain comparative sequence data 
for the analysis of structure-function relationships of the carbonic anhydrase 
isosymes during their evolution. 
MATERIALS AND METHODS 
CA I was purified from rhesus hemolysates by affinity chromatography on 
a sulfonamide (Prontosil) column (21). Since rhesus red cells contain both 
CA I and CA II, CA I was separated from CA II by selective elution with ICI. 
The purified protein was homogeneous as determined by starch gel electrophor- 
esis (1). 
TPCK-trypsin, chymotrypsin and carboxypeptidases A and B were obtained 
from Worthington Biochemical Corp., and thermolysin from Boehringer Mannheim 
Biochemicals. Carboxypeptidase Y, hydroxylamine-HCl, citraconic anhydride, 
cyanogen bromide and chemicals for the automatic sequencing were purchased 
from Pierce Chemical Co., and Sephadex gels from Pharmacia Fine Chemicals. 
All other chemicals were reagent grade quality. 
Tryptic digestion of rhesus CA I was carried out on acid denatured mate- 
rial as previously described (20). After digestion, the pH was adjusted to 
5.0, and peptides insoluble under these conditions were removed by centrifuga- 
tion. The soluble peptides were then separated either by ion exchange chrom- 
atography on Technicon type P resin (221, or by a combination of gel filtra- 
tion on Sephadex G-50 Fine columns and high voltage paper electrophoresis. 
The insoluble material was repeatedly washed with H20 to remove all 
soluble peptides. The insoluble peptides were then suspended in H20, solu- 
bilized by the addition of solid guanidine-HCl, fractionated on a 1 x 110 cm 
Sephadex G-50 Fine column, and eluted with 5 M guanidine-HCl, pH 5. 
Restriction of tryptic cleavage to arginyl bonds was accomplished by 
modifying the lysyl residues of purified rhesus CA I with citraconic anhydride 
as previously reported (20). Following dialysis to remOve by-products and 
excess reagents, the modified enzyme was treated with 2% TPCK-trypsin at pH 
8.5 for four hours. The digested material was fractionated using a 1.5 x 100 
cm Sephadex G-100 column equilibrated with 0.1 M acetic acid. 
Cleavage at both methionine and tryptophan residues with cyanogen bromide 
was performed essentially as described by 0~01s and Gerard (23). After the 
reagents had been removed by lyophilization, the mixture of fragments was 
dissolved in 3 M NH40H at room temperature for one hour in order to improve 
the yield of the fragments. The mixture was then separated on a 1 x 110 cm 
Sephadex 650 Superfine column in 5 M guanidine-HCl, pH 5. Cleavage at methi- 
onyl residues only was carried out with cyanogen bromide in 70% formic acid 
(24). 
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Cleavage of the only Asn-Gly bond (residues 24 and 25) was effected by 
hydroxylamine as described by Blumenfeld et al. (25). No separation of the 
cleaved material was attempted, and only a single sequence was seen when the 
mixture was sequenced. 
Certain peptides were further digested by chymotrypsin, thermolysin or 
carboxypeptidases (26-29). Amino acid analysis was carried out as previously 
described (20). 
The amino acid sequences were determined with the use of a Beckman 890B 
sequencer; details of the procedures employed have been previously reported 
(20) * The Beckman sequencing program No. 111374 was used through most of this 
work. We also observed that the addition of l-2 mg of human CA I to the sam- 
ple being sequenced greatly promoted retention of the peptide during the rou- 
tine extraction steps. Others have noticed a similar effect with other pm- 
teins (30). PTH-amino acids were identified using both gas chromatography 
(SP-400 or SE-30 coated supports) and polyamide-TLC plates (31). Arginine 
and histidine were identified by specific staining techniques (phenanthrene- 
quinone ma Pauly). 
RESULTS 
The results are summarized in Table I. 
Peptides obtained from tryptic hydrolysis of either unmodified or citra- 
conylated material covered the complete primary structure of rhesus CA I. 
Automatic sequencing procedures were straightforward and yielded data for all 
residues except l-10, 24-34 and 212-227. 
The N-terminal tryptic peptide (residues l-10) was sequenced by analysis 
of its C-terminal residues with carboxypeptidases A and B, and sequence ana- 
lyses or carboxypeptidase Y treatment of peptides produced by chymotryptic 
digestion of the intact tryptic peptide. This peptide was presumed to be 
acetylated at the N-terminus on the basis of its failure to undergo Edman 
degradation. 
The sequence of residues 212-227 was obtained by automatic sequencing 
of fragment 210-260 obtained from CNBr cleavage at Trp-209. 
Tryptic peptide 19-34 could only be sequenced for five steps after which 
no further residues were released. Thermolytic peptides were prepared and 
sequenced, leaving only residues 24-30 unresolved. Composition and electro- 
phoretic mobility indicated the possibility of an Asn-Gly sequence which is 
known to frequently block Edman degradation by forming a B-aspartyl bond. 
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TABLE 1 
Amino Acid Sequence of Rhesus Monkey Carbonic Anhydrase I 
t 
1 10 20 
(Ac)-Ala-Ser-Pro-Asp-Trp-Gly-Tyr-Asp-Asp-Lys-Asn-Gly-Pro-Glu-Gln-Trp-Ser-Lys-Leu-Tyr- 
f------- -_-_-_--- -- --Le.---L--++ *c---T 
,-L--L-+ f-------f- T-C 
21 30 Thr 40 
Pro-Ile-Ala-Asn-Gly-Asn-Asn-Gln-Ser-Pro-Val-Asp-Ile-Lys-Thr-Ser-Glu-~-Lys-His- 
-_-_-_-_-_-_-_-_-_-_----- - -_-_- - -_-_-_-_- + *t--T 
-t---t T-TL 
f HA 
41 50 60 
Asp-Thr-Ser-Leu-Lys-Pro-Ile-Ser-Val-Ser-Tyr-Asn-Pro-Ala-Thr-Ala-Lys-Glu-Ile-Ile- 
T 
61 70 80 
Asn-Val-Gly-His-Ser-Phe-His-Val-Asn-Phe-Glu-Asp-Asn-Asp-Asn-Arg-Ser-Val-Leu-Lys- 
l T 
81 90 99 Thr 
Gly-Gly-Pro-Phe-Ser-Asp-Ser-Tyr-Arg-Leu-P~e-Gl~-Phe-His-Phe-His-Trp-Gly-Ser-SER- 
T 
101 His 110 Ala 119 Val 
Asn-G1u-~-Gly-Ser-Glu-His-Thr-Val-Asp-Gly-Val-Lys-Tyr-Ser-SER-Glu-Leu-His-ILE- 
T 
A;a 122 130 Ala 140 
VAL-His-Trp-Asn-Ser-Ala-Lys-Tyr-Ser-Ser-L~u-Ala-Glu-Ala-VAL-Ser-Lys-Ala-Asp-Gly- 
+ : T 




161 Gln 170 180 
Leu-Asp-Ala-Leu-HIS-Ala-Ile-Lys-Thr-Lys-Gly-Lys-Arg-Ala-Pro-Phe-Thr-Asn-Phe-Asp- 
*f----f-- T 
--- ___ CNBr 
< T-tit 
181 190 Pro 200 
Pro-Ser-Thr-Leu-Leu-Pro-Ser-Ser-Leu-Asp-Phe-Trp-Thr-Tyr-~-Gly-Ser-Leu-Thr-His- 
T-tit 
< ---- Trp 
201 210 220 
Pro-Pro-Leu-Tyr-Glu-Ser-V~l-Thr-T~p-Ile-I~e-Cys-Lys-Glu-Ser-Ile-Ser-Val-Ser-Ser- 
+ -----_-_-_-_---_-_-_________________ T-,-it 
-_-_-____--_-_-___--------------- -+ + TrP 
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The whole protein was therefore treated with hydroxylamine and, as no other 
Asn-Gly sequence had been found, the cleavage mixture was sequenced directly 
yielding a single sequence starting at residue 25. 
DISCUSSION 
The complete primary sequence of rhesus macaque carbonic anhydrase I is 
shown in Table 1. The sequenced fragments were ordered by aligning them with 
the fully characterized sequence of human CA I (12-14). Those 13 residues 
which differ from human CA I are indicated. With the exception of the Ser/Asp 
difference at position 236, which requires two base changes, all of the 
replacements can result from single base mutations. 
When the specific esterase activities of rhesus and human CA I toward 
B-naphthyl acetate and pnitrophenyl acetate are compared, the activity of 
rhesus CA I is about 25 and five times, respectively, that of human CA I (1). 
This high specific esterase activity also appears to be a characteristic of 
the CA I isozymes of all of the species of the genus Macaca that have been 
tested in our laboratory (cf. ref. 32). Because of this marked increase in 
esterase activity, it was of interest to examine the putative active site 
residues of the human and rhesus isosymes, especially those proposed bv Arqos 
et al. (33) to be within binding distance of the aromatic structure of pnitro- -- 
phenyl acetate in human CA I. These residues are designated by an asterisk 
in Table 1. The only difference is at position 121 which is alanine; and 
which is, incidentally, also alanine in chimpanzee CA I (34) whose esterase 
activity is similar to that of human CA I (35). However, the fact that the 
t Solid lines indicate residues identified during automatic sequencing. Broken 
lines indicate that no positive identification was made. Fragments were 
obtained by cleavage with trypsin (T), chymotryptic cleavage of tryptic pep- 
tides (T-C), thermolytic cleavage of tryptic peptides (T-TL), tryptic cleavage 
after citraconylation (T-tit), cleavage of Met residues with cyanogen brcnnide 
(CNBr), cleavage of Met and Trp residues with cyanogen bromide (Trp), cleavage 
of Asn-Gly bonds with hydroxylamine (HA), and cleavage with carboxypeptidase 
(L-L-1. See text for details. Residues which differ from human CA I are 
underlined and capitalized; residues in human CA I are designated above. Ast- 
erisks indicate residues postulated to be within contact distance of the arom- 
atic structure of p-nitrophenyl acetate in human CA I (33). - 
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homologous residue at this position is valine in all other carbonic anhydrase 
isozymes that have been sequenced through this position, i.e., the CA I iso- 
zymes of orangutan (1,34) horse (15), ox (3), and turtle (6,34), the CA II 
isosymes of human (16,17), sheep (18), ox (19), and rabbit (20), and the mus- 
cle CA III isozyme of ox (3), suggests that the Val/Ala difference is not 
directly responsible for the higher esterase activity of rhesus CA I. The 
other residues that have their side chains in the active site of human CA I, 
i.e., positions 7, 61, 64, 65, 67, 69, 92, 96, 145, 199, 201, 202, 204, and 
206 (cf. ref. 36), are the same in rhesus CA I. Clearly, marked changes 
in enzyme activity can be produced by changes in residues which may not be 
located in the active site. In this respect, it is of interest to point out 
that the specific esterase activity of orangutan CA I is also considerably 
higher than that of human CA I (l), and as with rhesus CA I, no differences 
have as yet been found (with the exception of Val--121, see above) between the 
putative active sits residues of human and orangutan CA I (orangutan CA I res- 
idues at positions 207, 209, and 211 have not been sequenced). 
When the sequence of rhesus CA I is compared with the complete, or par- 
tially complete, sequences of the CA I isozymes of human (100% sequenced (16, 
17)3, chimpanzee [lOO% sequenced (34)1, orangutan (90% sequenced (1,34)], rab- 
bit [60% sequenced (l)], ox [lOO% sequenced (3)1, horse (100% sequenced (15)], 
and turtle (93% sequenced (6,34)1, an estimate of their evolutionary distances 
can be obtained. The sequence of rhesus CA I was found to differ from the 
CA I's of the above species by the following percentages: orangutan, 5%; chim- 
panzee, 5%; human, 5%; rabbit,16%;horse, 18%; ox, 20%; and turtle, 40%. 
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